Cell Preparations
T-DEPLETED SPLEEN CELLS. T cells were eliminated by exposure of spleen cells (3 X 107/ml) to mc-ot-Thy-l.2 (1:100) and then, after washing, to selected rabbit serum (complement [C] 1:9). The cycle was then repeated with mc-a-Lyt-1.2 (1:25) plus mc-a-Lyt-2.2 (1:25) in place of a-Thy-l.2. The two treatments were needed because spleen cells subjected to only the first treatment did generate substantial numbers of a-SRBC PFC when exposed to mitogenic quantities of concanavalin A (4/~g/ml), whereas twice-treated cells did not. The fact that the two treatments reduced a-SRBC PFC generation by 95% in the presence of purified T cell growth factor (TCGF; kindly provided by Dr. Steven Gillis, Fred Hutchinson Cancer Research Center, Seattle, WA) further emphasizes the efficacy of the dual procedure in eliminating residual T cells.
B CELLS. To remove Mq~, spleen cells (~18 × 107) were passed over a Sephadex G-10 column (bed volume, 30 ml; Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N J) and eluted with ~30 ml of RPMI 1640 (Grand Island Biological Co. Grand Island, NY) containing 20% fetal bovine serum (FBS) streptomycin (100 #g/ml) and penicillin (100 U/ml) (4) . Recovery was consistently 50-60% of the starting population. This treatment did not change the proportion of T and B cells significantly, but reduced the esterase-positive cells from 5-9% to <0.5% (5) . Efficacy of this procedure was further confirmed by functional assays (see Results). The eluted cells were treated with mc-a-Thy-1.2 plus mc-c~-Lyt-1.2 and me-a-Lyt-2.2, and C, to eliminate T cells (see above).
Mq~. Spleen cells (5 × 107) in 15 ml of RPMI 1640 plus 20% FBS were plated in each 100-ram plastic culture dish and incubated at 37°C in a humidified atmosphere of 10% CO2 and 90% air for 2 h. Nonadherent cells were then washed away, and adherent cells detached with a rubber policeman. The adherent cells were treated with mc-a-Thy-l.2 plus C and irradiated (1,500 rad). In the following text, these adherent Thy-1-and radi, oresistant cells are referred to as Mq~.
Mishetl-Dutton Culture. Spleen cells, T depleted or purified (as above), were cultured in RPMI 1640 supplemented with 10% FBS, L-glutamine (2 raM), 2-mercaptoethanol (5 × 10 -s M), sodium pyruvate (1 raM), streptomycin (100 #g/ml), penicillin (100 U/ml), and Hepes buffer (10 mM) in 16-ram flat-bottomed Linbro plates (Linbro Chemical Co., Hamden, CT) with SRBC (5 × 106) at 37°C in a humidified atmosphere of 10% CO2 and 90% air with daily feeding as described elsewhere (3). 
Plaque-forming

Preparation of Factors
MLC-SN. 5 × 106 B6 spleen cells were stimulated with 5 × 106 irradiated DBA/2 spleen cells (2,000 rad) in 1 ml of Mishell-Dutton medium (MDM) in a Linbro well. 24 h later, the supernatant was centrifuged, passed through 0.45-#m filter (Millipore Corp., Bedford, MA), and stored at -20°C. This preparation showed a low but significant level of interleukin 2 (IL-2) activity determined by TCGF assay, and may contain a factor similar to late-acting T cellreplacing factor. The B cell helper activity of Mq~-derived factors (e.g., IL-1) was minimized by reducing the concentration of MLC-SN (see Results).
SUPERNATANT FROM P388D.| CELLS (MI~-SN), As a source of M~b-derived factors, 2 × 106 P388D. 1 cells (a DBA/2 M~ cell line kindly provided by Dr. Peter Ralph, Memorial SloanKettering Cancer Center) were cultured in 1 ml of MDM with 0.01 /xg/ml Escherichia coli lipopolysaccharide (LPS; 055:B5, Difco Laboratories, Detroit, MI) in a Linbro well for 4 d (7). The cell-free SN was dialyzed against 100 vol of RPMI 1640 for 24 h, filtrated, stored at -20°C, and used at a concentration of 0.5%. 
Results
Properties of the MLC-SN and M~b-SN Preparations
0+0
Second experiment Thus, the MS depletion procedure is evidently adequate. At high concentration, the MLC-SN preparation used has appreciable MS-replacing activity (possibly of M~ origin, e.g., IL-1), but this activity is negligible at the selected concentration of 10-15% MLC-SN. Therefore, under the conditions described, the helper actions of MLC-SN and Mq~-SN can be ascribed to T cells and Mq~, respectively, and both are required for maximal PFC response. (Table II) . MS were (Table III) . The fact that Lyb-2 antibody blocked generation of PFC to T-dependent but not to T-independent antigen (3) could mean that Lyb-2 antibody interferes with a reaction between T and B cells, one such reaction being the reception of T helper factors by B cells. Accordingly, having shown that the background helper activity attributable to Mq~ factors in 15% MLC-SN is negligible (Table I) , we tested the possibility that Lyb-2 molecules serve as receptors for T helper factors. For this purpose, we used T-depleted spleen cell (B + M~) as responder cells, and MLC-SN (15%), added at 44 h, as a source of T helper factors. Representative data are given in Table III (experiment 1) . The rationale for these experiments was that if Lyb-2 antibody acted simply by blocking the receptor sites for T helper factors, then Lyb-2 antibody added at 44 h, the time of adding MLC-SN, should effectively block the response. In the event, when antibody was added at the initiation of culture, there was maximal PFC reduction, but when antibody was added at 44 h there was no reduction. These results indicate that Lyb-2 is not involved in the reception of T helper factors present in MLC-SN, and imply that Lyb-2 functions at some point in a process that occupies about 44 h after stimulation by antigen and precedes the operation oft helper factors. This places the time of action of Lyb-2 antibody within 
Evidence That Lyb-2 Antibody Acts on B Cells and Not on Mep
Lyb-2 Antibody Does Not Block Reception of Helper Factors Present in MLC-SN or MO-SN
Period of Action of Lyb-2 Antibody
Period of culture with mc-a-Lyb-2.1 PFC response (1:100) plus SRBC % standard 
Evidence That Lyb-2 Antibody Acts During the Triggering of B Cells by Antigen
PERIOD OF ACTION OF LYB-2 ANTIBODY. Purified B cells were exposed to SRBC plus Lyb-2 antibody for 2-20 h, freed of SRBC, washed, and cultured with fresh SRBC. M@SN (0.5%) and MLC-SN (10%) were added at 20 and 44 h, respectively. Table  IV indicates that maximal reduction of PFC by Lyb-2 antibody requires the presence of this antibody for >4 and <20 h after exposure to antigen.
ONLY ANTIGEN-TRIGGERED B CELLS ARE AFFECTED BY LYB-2 ANTIBODY.
In the experiments summarized in Table V , purified B cells were cultured with Lyb-2 antibody for 20 h, with or without SRBC, and the SRBC and excess antibody then removed. The cells were then cultured again, without antibody, with either SRBC or HRBC. Mt~-SN and MLC-SN were added at 20 and 44 h, respectively, after the first exposure to SRBC or HRBC (whichever was to assayed for PFC response). Group A of Table  V shows again (as in Table IV ) that exposure to SRBC plus Lyb-2 antibody (1st culture) abolished the subsequent capacity of the responding population (2nd culture) to give a maximal PFC response to SRBC in the absence of Lyb-2 antibody. Group B shows that exposure to Lyb-2 antibody alone in the absence of antigen did not affect the subsequent response to SRBC. Group C shows that the exposure to SRBC plus Lyb-2 antibody did not affect the subsequent PFC response to HRBC. Thus, Lyb-2 antibody evidently acts during the triggering process induced by reaction of antigen with B cells. Blocking by Lyb-2 antibody activity cannot be explained simply as a negative effect on all B cells regardless of their specificities.
Discussion
Of the several possible mechanisms whereby Lyb-2 antibody might block T-assisted generation of PFC, some can now be excluded. Lyb-2 antibody does not interfere with reception of M~-derived factors in the supernatant of P388D. 1 cells, nor with the reception of MLC-associated factors, and its time of action is previous to the acquisition of responsiveness to these signals. This places the function of Lyb-2 within the period of antigen-triggered B cell stimulation. The fact that Lyb-2 antibody blocks the generation only of PFC derived from B cells concurrently exposed to antigen (the remaining B cells responding normally to a subsequent second antigen after Lyb-2 antibody is removed) indicates that the Lyb-2 cell surface component is somehow involved in a differentiative process ('proliferative' step) initiated by binding of antigen. The Lyb-2 molecule is not the sIg receptor for antigen: its structure is inappropriate (8) , rabbit a-mouse Ig does not block serological absorption of a-Lyb-2 (unpublished data), and there is no known reason why blocking of the antigen receptor should affect only T-dependent antigen.
Two sorts of action, not necessarily exclusive of one another, can be suggested for the function of Lyb-2. First, Lyb-2 may be involved in internal transmission of a proliferative stimulus, for example, the mitogenic component in FBS, which in our experience (unpublished results) is needed for an a-SRBC response but is not essential to demonstrable TNP-Ficoll and TNP-Brucella responses. In the same context, Lyb-2 may participate in molecular rearrangements ('cross-linking') ofsIg receptors required for response to T-dependent antigen.
Second, Lyb-2 molecules might be concerned in the phenotypic expression or presentation of receptors for differentiative signals from Mq~ or T cells, presumably affecting their numbers, affinity, or conformation. The finding that MLC-SN is more effective on day 2 of culture than at the start (9) may be a hint that the receptor phenotype, as well as the number of responsive B cells, is important to efficient PFC generation. In this context, the report that resting or unstimulated B cells were not responsive to proliferative and differentiative signals until stimulated by LPS (10) makes us wonder whether the expression and display of signal receptors on B cells are subject to the same kinds of regulation as hormone receptors in classical endocrine system (11, 12) .
Summary
The generation of plaque-forming cells (PFC) to T-dependent antigen, but not to T-independent antigen, is reduced in vitro by Lyb-2 antibody. Monoclonal Lyb-2 antibody, added to Mishell-Dutton cultures within the first 2 d, but not later, greatly reduces the generation of a-sheep erythrocyte (SRBC) PFC from T-depleted spleen cells whether help is provided in the form of intact T cells or as soluble factors contained in mixed lymphocyte culture (MLC) supernatants. Generation of a-SRBC PFC from purified B cells, assisted by soluble factors in MLC and macrophage (P388D.1 cell) supernatants, is similarly reduced by Lyb-2 antibody. The initial 2-d period, during which cultures are diminishingly sensitive to reduction of PFC generation by Lyb-2 antibody, is not affected by the time at which such soluble factors are added. Thus, Lyb-2 cell surface molecules evidently do not function as receptors for these differentiative signals.
Reduction of PFC generation by Lyb-2 antibody is antigen dependent in the sense that reduction of the PFC response to one antigen (SRBC) does not affect subsequent generation of PFC to a second antigen (horse erythrocytes) from the same cell population. These findings accord with the view that the Lyb-2 molecule participates in a B cell differentiative phase, probably proliferative, which begins with binding of antigen and precedes the phase in which B cells become fully receptive to signals from T and other ceils.
